Martin Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$4.45M |
| 2 |
VGNT
Versigent PLC
VGNT
|
+$1.01M |
| 3 |
Monopar Therapeutics
MNPR
|
+$144K |
| 4 |
Medtronic
MDT
|
+$2.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Check Point Software Technologies
CHKP
|
+$16.4M |
| 2 |
Futu Holdings
FUTU
|
+$15.2M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$4.7M |
| 4 |
Apple
AAPL
|
+$2.77M |
| 5 |
AstraZeneca
AZN
|
+$2.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.73% |
| 2 | Technology | 20.7% |
| 3 | Financials | 19.65% |
| 4 | Industrials | 13.22% |
| 5 | Consumer Discretionary | 12.81% |
Similar funds
Martin Investment Management's Q2 2026 Portfolio in Review
As of Q2 2026, Martin Investment Management held 49 positions worth $300M, down 10% from $334M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Martin Investment Management withdrew a net $42.9M in Q2 2026, closing 2 positions and reducing 36 holdings. Its most notable exit was Check Point Software Technologies, an estimated $16.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Technology and Financials.
Against the trend, Martin Investment Management opened a new position in Newmont worth $3.81M.
- Martin Investment Management's largest Q2 2026 buy was Newmont: 40,828 shares worth $3.81M.
- Martin Investment Management added most to Medtronic in Q2 2026, an estimated $2.9K increase.
- Martin Investment Management's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $4.7M.
- Martin Investment Management fully exited Check Point Software Technologies in Q2 2026, selling an estimated $16.4M.
- Martin Investment Management's ten largest holdings make up 58% of its $300M portfolio in Q2 2026.
- Martin Investment Management opened 3 new positions and closed 2 in Q2 2026.
- Martin Investment Management's portfolio value fell 10% quarter-over-quarter to $300M.
Based on Martin Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.